// Research Reviews
Post-Cycle Therapy: What It Is and Why Timing Governs Everything
Aug 26, 2026 · 6 min read
Any external anabolic hormone — prescribed or otherwise — suppresses your body’s own testosterone production through the feedback loop described in our HCG article. Post-cycle therapy (PCT) is the process of restarting that natural production after the external supply stops.
This article explains the concept and the physiology. It deliberately contains no dosing protocols: the medications involved are prescription drugs, the correct protocol depends on your bloodwork and history, and anyone who needs one should be working with a physician. What you should walk away with is an understanding of why PCT exists and why its timing is the whole game.
Why coming off is hard
When external hormones stop, there’s a gap: the compounds are clearing your system, but your natural production hasn’t restarted yet. In that gap, hormone levels fall below baseline — and the symptoms are exactly what low hormones predict: low mood, fatigue, loss of lean tissue, fat gain, disrupted libido and sleep. For some people this period is a mild slump. For others it’s a genuine physical and psychological struggle.
PCT exists to shorten that gap. The medications physicians use in this context — SERMs such as clomiphene and tamoxifen, and in some cases HCG — work by stimulating the hormonal signals that restart natural production. Which are used, in what combination, and for how long depends on the individual. That is precisely the part that requires medical supervision and follow-up bloodwork.
Why timing governs everything
The most common PCT failure is starting too early. Injectable compounds are attached to esters that control their release rate, and long-ester compounds remain active in the body for weeks after the last administration — some for months. Starting a restart protocol while external hormones are still suppressing the system is like trying to start a car with the handbrake on: effort expended, nothing achieved.
The principle is simple: the restart begins when the suppressing compounds have cleared, and clearance time depends on what was used and for how long. Short-acting compounds clear in days; long-acting ones take weeks. A physician working from bloodwork — not a forum working from averages — is how that timing gets set correctly.
Who this applies to — and who it doesn’t
Two groups don’t follow this model. Men on physician-managed TRT don’t cycle off — a therapeutic protocol is continuous by design, so there’s no “post-cycle” to manage; the relevant question for them is maintaining function during therapy, which is where HCG enters the picture. And the suppression dynamics described here apply to male physiology; they don’t map onto women in the same way.
For everyone else, the honest framing is this: if someone is willing to invest in altering their physiology, the willingness to do the exit properly — timed correctly, monitored with bloodwork, verified with follow-up labs — is part of the same discipline. The people who skip it don’t save effort. They borrow symptoms.
The endpoint of any restart process is verification: bloodwork confirming that natural production has actually returned to range. Feeling fine is not a measurement. The labs don’t lie.
// Educational content only. Not medical advice. PCT medications are prescription drugs — all decisions belong to you and a licensed physician.
// Next step
Reading is education. Bloodwork is measurement. If you want this applied to your physiology, the application is the door.